Professor Sir Philip Cohen, one of the UK’s most respected scientists, has been awarded new research grants that will mean his work at the University of Dundee has been funded continuously for 50 years. Sir Philip is a biochemist who has made major contributions to our understanding of protein phosphorylation and its role in cell regulation and human disease. Phosphorylation processes are very important because...
Designer and manufacturer of prosthetic technologies, Össur, has shown its commitment to Scotland with an agreement to invest £5.6m over a three-year period to develop prosthetic hand and arm solutions at its Touch Bionics operations. The company’s investment is being supported by a £1.3m grant from Scottish Enterprise, to see Touch Bionics deliver on innovative R&D projects and creating an additional four high value R&D...
Life sciences giant Merck has invested £1 million to expand its Glasgow site as it eyes its continuing expansion. The company said the investment will support its BioReliance services portfolio, which delivers biosafety testing services to the global pharmaceutical and biotech industries. These services are crucial in ensuring medicines are safely released to patients around the world. The Glasgow investment, which has involved the installation of new...
A Scottish company at the forefront of genetic medical research has been awarded a £1.9 grant to expand its programme of cell and gene therapy. Synpromics Ltd, based in Roslin, is pioneering research that could unlock a one treatment cure for diseases such as leukaemia and certain types of blindness. The Scottish Enterprise research and development (R&D) grant will enable the firm to invest a...
3F BIO Ltd, a Scottish biotech company whose purpose is to tackle the combined issues of feeding a growing global population and the unsustainable impact of traditional protein farming, has confirmed a £6.16M Series A financing round that will be used to scale up and commercialise its zero-waste process. The funding provides strong support and validation for 3F BIO’s technology, which transforms cereal crops such...
Glasgow based Formedix has announced its partnership with The iMATCH (Innovate Manchester Advanced Therapy Centre Hub) consortium. The recently formed Manchester consortium, led by The Christie, has been awarded almost £7 million of funding, to advance a new generation of therapies for cancer, genetic and degenerative diseases. Manchester is one of only three centres in Britain awarded funding by Innovate UK, the government’s innovation agency, to coordinate a...